Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies

Yanyang Nan; Dianwen Ju; Xuyao Zhang

doi:10.3389/fimmu.2023.1250975

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies

Front Immunol. 2023 Aug 11:14:1250975. doi: 10.3389/fimmu.2023.1250975. eCollection 2023.

Authors

Yanyang Nan¹, Dianwen Ju¹, Xuyao Zhang¹

Affiliation

¹ Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.

No abstract available

Keywords: cancer immunotherapy; combination therapy; immune checkpoint inhibitors; novel targets; therapy strategies.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents
Anti-Infective Agents*
Humans
Neoplasms* / therapy
Penicillins
Pulmonary Surfactants*

Substances

Anti-Bacterial Agents
Penicillins
Anti-Infective Agents
Pulmonary Surfactants

Grants and funding

This research was funded by National Natural Science Foundation of China (32200745, and 82073752), Shanghai Sailing Program (21YF1401900), Scientific and Innovative Action Plan of Shanghai (20S11904700 and 20JC1411000).